Cash-strapped Vincerx left mulling future after Oqory reverse merger falls apart
Oqory’s planned reverse merger with fellow antibody-drug conjugate company Vincerx Pharma has fallen apart at the last minute, leaving Vincerx to size up its remaining options in the final months before its cash runs dry.
Oqory’s planned reverse merger with fellow antibody-drug conjugate company Vincerx Pharma has fallen apart at the last minute, leaving Vincerx to size up its remaining options in the final months before its cash runs dry.
